← Leaderboards
Stephen F Konieczny
Purdue University West Lafayette
$13,212,852
Attributed
$13,873,639
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$13,873,639 · 8
By mechanism
R01$10,631,826 · 4
P30$3,241,813 · 4
Top collaborators
- Matthew J. Flick3 shared
Most similar at Purdue University West Lafayette
Same institution · by research overlap
- Richard F Borch$1,501,932
- Ourania M. Andrisani$9,165,271
- Richard D Mattes$7,135,496
- H Lee Weith$433,932
- David J Waters$915,419
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsCellsBaseGenesGene TargetingMolecularProto-OncogenesCell LineageGenetic TranscriptionAcinar CellComplexMouse ModelBiological ModelsRegulatory PathwayMalignant Neoplasm Of PancreasTranscription FactorFutureSignal TransductionMalignant NeoplasmsNeoplasm MetastasisGrowthHuman DiseasePancreasEvent
Grant awards (52)
Transgenic and Genome Editing Facility (TGEF-SR)$191,772
P30 · FY2024 · CA · contact PI
Transgenic and Genome Editing Facility (TGEF-SR)$191,772
P30 · FY2023 · CA · contact PI
Transgenic and Genome Editing Facility (TGEF-SR)$191,772
P30 · FY2022 · CA · contact PI
Transgenic and Genome Editing Facility (TGEF-SR)$191,772
P30 · FY2021 · CA · contact PI
Transgenic and Genome Editing Facility (TGEF-SR)$191,772
P30 · FY2020 · CA · contact PI
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease$473,443
R01 · FY2019 · CA
Transgenic Mouse Core Facility Shared Resource (TMCF-SR)$245,589
P30 · FY2019 · CA · contact PI
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease$417,066
R01 · FY2018 · CA
Transgenic Mouse Core Facility Shared Resource (TMCF-SR)$239,539
P30 · FY2018 · CA · contact PI
Transgenic Mouse Core Facility Shared Resource (TMCF-SR)$7,467
P30 · FY2018 · CA · contact PI
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease$431,066
R01 · FY2017 · CA
Pancreas Transcription Factors and Disease Model Systems$322,868
R01 · FY2017 · DK · contact PI
Kras-Induced Cellular Plasticity in Pancreatic Cancer$312,367
R01 · FY2017 · CA · contact PI
Transgenic Mouse Core Facility Shared Resource (TMCF-SR)$199,523
P30 · FY2017 · CA · contact PI
Pancreas Transcription Factors and Disease Model Systems$323,443
R01 · FY2016 · DK · contact PI
Kras-Induced Cellular Plasticity in Pancreatic Cancer$312,577
R01 · FY2016 · CA · contact PI
Transgenic Mouse Core Facility Shared Resource (TMCF-SR)$233,872
P30 · FY2016 · CA · contact PI
Pancreas Transcription Factors and Disease Model Systems$323,991
R01 · FY2015 · DK · contact PI
Kras-Induced Cellular Plasticity in Pancreatic Cancer$312,255
R01 · FY2015 · CA · contact PI
Transgenic Mouse Core Facility Shared Resource (TMCF-SR)$187,263
P30 · FY2015 · CA · contact PI
Pancreas Transcription Factors and Disease Model Systems$324,513
R01 · FY2014 · DK · contact PI
Kras-Induced Cellular Plasticity in Pancreatic Cancer$302,844
R01 · FY2014 · CA · contact PI
Transgenic Mouse$168,266
P30 · FY2014 · CA · contact PI
Kras-Induced Cellular Plasticity in Pancreatic Cancer$312,166
R01 · FY2013 · CA · contact PI
Pancreas Transcription Factors and Disease Model Systems$297,463
R01 · FY2013 · DK · contact PI
Transgenic Mouse$125,944
P30 · FY2013 · CA · contact PI
Pancreas Transcription Factors and Disease Model Systems$308,761
R01 · FY2012 · DK · contact PI
Kras-Induced Cellular Plasticity in Pancreatic Cancer$300,006
R01 · FY2012 · CA · contact PI
Transgenic Mouse$137,015
P30 · FY2012 · CA · contact PI
Pancreas Transcription Factors and Disease Model Systems$309,238
R01 · FY2011 · DK · contact PI
Kras-Induced Cellular Plasticity in Pancreatic Cancer$302,482
R01 · FY2011 · CA · contact PI
Transgenic Mouse$148,745
P30 · FY2011 · CA · contact PI
Pancreas Transcription Factors and Disease Model Systems$375,708
R01 · FY2010 · DK · contact PI
Kras-Induced Cellular Plasticity in Pancreatic Cancer$313,971
R01 · FY2010 · CA · contact PI
Transgenic Mouse$155,798
P30 · FY2010 · CA · contact PI
Pancreas Transcription Factor and Disease Model System$321,551
R01 · FY2009 · DK · contact PI
Kras-Induced Cellular Plasticity in Pancreatic Cancer$314,287
R01 · FY2009 · CA · contact PI
Pancreas Transcription Factor and Disease Model System$322,202
R01 · FY2008 · DK · contact PI
Kras-Induced Cellular Plasticity in Pancreatic Cancer$314,555
R01 · FY2008 · CA · contact PI
Pancreas Transcription Factor and Disease Model System$329,400
R01 · FY2007 · DK · contact PI
Pancreas Transcription Factor and Disease Model System$339,838
R01 · FY2006 · DK · contact PI
Pancreas Transcription Factor and Disease Model System$348,577
R01 · FY2005 · DK
PANCREAS TRANSCRIPTION FACTORS AND CANCER MODEL SYSTEMS$292,883
R01 · FY2004 · DK
PANCREAS TRANSCRIPTION FACTORS AND CANCER MODEL SYSTEMS$284,961
R01 · FY2003 · DK
PANCREAS TRANSCRIPTION FACTORS AND CANCER MODEL SYSTEMS$294,271
R01 · FY2002 · DK
Core--Transgenic mouse$216,966
P30 · FY2002 · CA
TRANSCRIPTIONAL CIRCUITS CONTROLLING MYOGENESIS$292,403
R01 · FY2001 · AR
PANCREAS TRANSCRIPTION FACTORS AND CANCER MODEL SYSTEMS$258,354
R01 · FY2001 · DK
Core--Transgenic mouse$216,966
P30 · FY2001 · CA
TRANSCRIPTIONAL CIRCUITS CONTROLLING MYOGENESIS$283,028
R01 · FY2000 · AR
PANCREAS TRANSCRIPTION FACTORS AND CANCER MODEL SYSTEMS$259,288
R01 · FY2000 · DK
Core--Transgenic mouse$0
P30 · FY2000 · CA